Antipodes Partners »

Terns Pharmaceuticals shares owned by Antipodes Partners

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Antipodes Partners from 13F filings

Historical chart of Antipodes Partners investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Antipodes Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Antipodes Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $24k 455 52.72

More positions owned by Antipodes Partners

Amazon (AMZN)
American Electric Power Company (AEP)
Microsoft Corporation (MSFT)
Exelon Corporation (EXC)
Merck & Co (MRK)
Sempra Energy (SRE)
Ferrovial Se (FER)
Barrick Mining Corp (B)
Brookdale Senior Living (BKD)
Ameren Corporation (AEE)
Hca Holdings (HCA)
Capital One Financial (COF)
Total Sa New Ord F (TTE)
Crown Castle Intl (CCI)
SJW (HTO)

View all positions for Antipodes Partners

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
Adage Capital Partners GP
Vanguard Group
Vanguard Capital Management
venBio Select Advisor
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals